Bain Capital Life Sciences Investors as of Sept. 30, 2022
Portfolio Holdings for Bain Capital Life Sciences Investors
Bain Capital Life Sciences Investors holds 33 positions in its portfolio as reported in the September 2022 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Springworks Therapeutics (SWTX) | 16.5 | $138M | 4.8M | 28.53 | |
| Nuvalent Inc-a (NUVL) | 8.0 | $67M | 3.4M | 19.44 | |
| Mersana Therapeutics (MRSN) | 7.0 | $59M | 8.7M | 6.76 | |
| Arcutis Biotherapeutics (ARQT) | 6.8 | $57M | 3.0M | 19.11 | |
| Dynavax Technologies Corp Com New (DVAX) | 6.7 | $57M | 5.4M | 10.44 | |
| Eqrx | 5.9 | $50M | 10M | 4.95 | |
| Crinetics Pharmaceuticals In (CRNX) | 5.4 | $45M | 2.3M | 19.64 | |
| Third Harmonic Bio (THRD) | 5.2 | $43M | 2.3M | 18.97 | |
| Amylyx Pharmaceuticals (AMLX) | 3.4 | $29M | 1.0M | 28.15 | |
| Rapid Micro Biosystems Class A Com (RPID) | 3.3 | $27M | 8.4M | 3.23 | |
| Cara Therapeutics (CARA) | 3.0 | $25M | 2.6M | 9.36 | |
| Pharvaris N V (PHVS) | 2.9 | $24M | 3.2M | 7.67 | |
| Nurix Therapeutics (NRIX) | 2.8 | $24M | 1.8M | 13.03 | |
| Annexon (ANNX) | 2.7 | $22M | 3.6M | 6.18 | |
| 2seventy Bio Common Stock (TSVT) | 2.4 | $21M | 1.4M | 14.55 | |
| Protagonist Therapeutics (PTGX) | 2.3 | $19M | 2.3M | 8.43 | |
| Savara (SVRA) | 2.2 | $18M | 12M | 1.55 | |
| C4 Therapeutics Com Stk (CCCC) | 1.7 | $14M | 1.6M | 8.77 | |
| Atea Pharmaceuticals (AVIR) | 1.7 | $14M | 2.5M | 5.69 | |
| X4 Pharmaceuticals (XFOR) | 1.3 | $11M | 6.4M | 1.71 | |
| ACADIA Pharmaceuticals (ACAD) | 1.2 | $10M | 611k | 16.36 | |
| Marinus Pharmaceuticals Com New (MRNS) | 1.1 | $9.5M | 1.4M | 6.65 | |
| Xilio Therapeutics (XLO) | 1.0 | $8.2M | 2.8M | 2.91 | |
| Syros Pharmaceuticals Com New (SYRS) | 0.8 | $7.0M | 1.1M | 6.44 | |
| Tango Therapeutics (TNGX) | 0.8 | $7.0M | 1.9M | 3.62 | |
| Adagio Therapeutics (IVVD) | 0.7 | $6.1M | 1.9M | 3.13 | |
| Arya Sciences Acquisitn Corp Class A Ord Shs | 0.6 | $4.9M | 500k | 9.81 | |
| Bcls Acquisition Corp Com Cl A | 0.6 | $4.9M | 488k | 10.02 | |
| Nautilus Biotechnology (NAUT) | 0.5 | $4.2M | 2.0M | 2.12 | |
| Solid Biosciences | 0.4 | $3.7M | 7.9M | 0.47 | |
| Aptinyx | 0.4 | $3.3M | 8.9M | 0.37 | |
| Frazier Lifesciences Acqu Unit 12/09/2025 | 0.4 | $3.0M | 300k | 10.15 | |
| Aeglea Biotherapeutics | 0.3 | $2.8M | 5.3M | 0.53 |
